Tradeshows
Subscribe for Free!
- Recent Posts
- Patient in ACTC Stem Cell Clinical Trial With Dry AMD Goes from Legally Blind (20/400) to Near Normal Vision (20/40)
- Current Status of Stem Cells and Gene Therapy in Ophthalmology
- RetroSense Using Optogenetics to Treat Retinitis Pigmentosa and Dry AMD
- Hemera Biosciences Obtains Initial Funding for Gene-based Treatment for AMD
- Probing to Treat Meibomian Gland Dysfunction
Blog Topics


